Insights from 2023 ASCO® Annual Meeting


 

Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in Patients With mCRPC: Final Analysis of ORR, rPFS, and OS

331 views
September 12, 2023
0 Comments
Login to view comments. Click here to Login
GU